Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-5,569
Closed -$253K 505
2017
Q2
$253K Buy
5,569
+569
+11% +$25.1K ﹤0.01% 404
2017
Q1
$213K Sell
5,000
-433
-8% -$17.7K ﹤0.01% 411
2016
Q4
$218K Buy
+5,433
New +$210K ﹤0.01% 360
2015
Q4
Sell
-1,637
Closed -$64K 609
2015
Q3
$64K Buy
1,637
+806
+97% +$32K ﹤0.01% 486
2015
Q2
$32K Buy
831
+694
+507% +$24.3K ﹤0.01% 549
2015
Q1
$5K Buy
137
+114
+496% +$3.5K ﹤0.01% 787
2014
Q4
$1K Buy
+23
New +$594 ﹤0.01% 625

Other funds holding HOLX

Wealthfront's HOLX Position: Q3 2017 in Review

Wealthfront sold out of Hologic (HOLX) in Q3 2017, closing a stake of 5,569 shares — an estimated $253K sold.

Wealthfront first reported a position in HOLX in Q4 2014 and held it in 7 quarters. The position peaked at $253K in Q2 2017. 457 funds tracked by Wall St. Rank hold HOLX as of Q3 2017.

  • Wealthfront reported no remaining Hologic position as of Q3 2017 after selling out during the quarter.
  • Wealthfront sold 5,569 Hologic shares in Q3 2017, an estimated $253K.
  • Wealthfront first reported a position in Hologic in Q4 2014 and held it in 7 quarters.
  • Wealthfront's Hologic position peaked at $253K in Q2 2017.
  • 457 funds tracked by Wall St. Rank held Hologic as of Q3 2017.

Based on Wealthfront's 13F filing for Q3 2017, filed 14 Nov 2017.